Holen Sie sich die Stockscreener-App
79.26
1.90%
-1.4418
Schlusskurs vom Vortag:
$80.70
Offen:
$80.22
24-Stunden-Volumen:
52,486
Relative Volume:
0.08
Marktkapitalisierung:
$4.37B
Einnahmen:
$1.43B
Nettoeinkommen (Verlust:
$107.13M
KGV:
40.91
EPS:
1.9372
Netto-Cashflow:
$161.04M
1W Leistung:
-3.92%
1M Leistung:
+3.87%
6M Leistung:
+27.57%
1J Leistung:
+34.83%
1-Tages-Spanne:
$79.03
$80.37
1-Wochen-Bereich:
$79.03
$83.52
52-Wochen-Spanne:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
79.28 | 4.45B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
106.12 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.82 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.78 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.60 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.46 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - Stock Titan
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - Stock Titan
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - Yahoo Finance
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - AD HOC NEWS
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - Stock Titan
LivaNova PLC (LIVN) director sells 1,650 shares - Stock Titan
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - AD HOC NEWS
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - Sahm
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) Q2 2026 Earnings Call Transcript - AOL.com
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares - Stock Titan
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN) - Yahoo Finance
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance - Yahoo Finance
LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale - Stock Titan
LivaNova PLC (LIVN) Stock Forecasts - Yahoo! Finance Canada
LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026What's Changed - webull.com
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP - MarketBeat
Price to earnings forward of LivaNova Plc – FWB:LIA - TradingView
LivaNova revenue increases 10.8% in Q2 2026 - medicalbuyer.co.in
LivaNova PLC (LIVN) Stock News Today - TradingKey
LivaNova PLC (LIA) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova PLC (LIA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised - Zacks Investment Research
LivaNova Sees Solid Demand in Both Cardiopulmonary and Neuromodulation - Morningstar
FMR LLC (LIVN) discloses 5.8% LivaNova stake in Schedule 13G filing - Stock Titan
LivaNova Earnings: Robust Second Quarter Builds on Strength in First Quarter - Morningstar
LivaNova (NASDAQ:LIVN) Releases Quarterly Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):